<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="courier ; font-style : italic;} BMC Infect DisBMC Infect. DisBMC" exact="Infectious" post="Diseases1471-2334BioMed CentralLondon pmcid: 74049115304 doi: 10.1186/s12879-020-05304-z : Research Article"/>
 <result pre="CentralLondon pmcid: 74049115304 doi: 10.1186/s12879-020-05304-z : Research Article Characteristics of" exact="tuberculosis" post="patients in the integrated tuberculosis control model in Chongqing,"/>
 <result pre=": Research Article Characteristics of tuberculosis patients in the integrated" exact="tuberculosis" post="control model in Chongqing, China: a retrospective study ZhangLiwen763336760@qq.com12XingWei502125258@qq.com1ZhouJiani1006181428@qq.com1ZhangRuiRenee1296@163.com1ChengYong245653660@qq.com1LiJin352366126@qq.com1WangGeng69273890@qq.com1LiuShili286535624@qq.com1http://orcid.org/0000-0002-8017-1488LiYinglilyliying2012@163.com1[1],"/>
 <result pre="ranks second in the world in terms of numbers of" exact="tuberculosis" post="(TB) cases and is one of the top three"/>
 <result pre="also has high mortality and low cure rates of human" exact="immunodeficiency" post="virus (HIV)-positive TB patients. This study aimed to analyse,"/>
 <result pre="DR-TB; young unemployed men have a higher risk of contracting" exact="HIV-positive" post="TB. The demographic and clinical characteristics of TB patients"/>
 <result pre="TB patients should be taken into consideration in DR-TB and" exact="HIV-positive" post="TB screening in the future. Keywords Tuberculosis Drug-resistant tuberculosis"/>
 <result pre="in DR-TB and HIV-positive TB screening in the future. Keywords" exact="Tuberculosis" post="Drug-resistant tuberculosis HIV-positive tuberculosis Retreatment Funding National Natural Science"/>
 <result pre="and HIV-positive TB screening in the future. Keywords Tuberculosis Drug-resistant" exact="tuberculosis" post="HIV-positive tuberculosis Retreatment Funding National Natural Science Foundation of"/>
 <result pre="HIV-positive TB screening in the future. Keywords Tuberculosis Drug-resistant tuberculosis" exact="HIV-positive" post="tuberculosis Retreatment Funding National Natural Science Foundation of China81773489LiYing"/>
 <result pre="TB screening in the future. Keywords Tuberculosis Drug-resistant tuberculosis HIV-positive" exact="tuberculosis" post="Retreatment Funding National Natural Science Foundation of China81773489LiYing Funding"/>
 <result pre="and Technology Innovation Subject in Chongqingcstc2015shmszx120070LiYing Funding Technology Basic and" exact="Advanced" post="Research Projects in Chongqing cstc2014jcyjA10069LiYing Background Tuberculosis (TB) is"/>
 <result pre="Technology Basic and Advanced Research Projects in Chongqing cstc2014jcyjA10069LiYing Background" exact="Tuberculosis" post="(TB) is one of the top ten causes of"/>
 <result pre="causes of death worldwide and is the leading cause of" exact="infectious diseases" post="[1]. According to the World Health Organization (WHO)â€˜s Global"/>
 <result pre="TB (RR/TB) in 2018 [1]. Drug-resistant TB (DR-TB) and TB/human" exact="immunodeficiency" post="virus (HIV) co-infection are the challenges in controlling TB"/>
 <result pre="the challenges in controlling TB (endeavours) worldwide. TB killed 251,000" exact="HIV-positive" post="people globally in 2018, although the number of TB"/>
 <result pre="globally in 2018, although the number of TB deaths among" exact="HIV-positive" post="people has fallen from 620,000 in 2000 to 251,000"/>
 <result pre="more complicated and challenging [2]. It was previously proven that" exact="HIV-positive" post="patients are vulnerable to DR-TB, and DR-TB is often"/>
 <result pre="HIV [3, 4]. A higher mortality rate was observed in" exact="HIV-positive" post="TB patients [5], and TB patients co-infected with HIV"/>
 <result pre="patients co-infected with HIV were more likely to develop extra-pulmonary" exact="disease" post="[6, 7]. Furthermore, hepatotoxicity is one of the most"/>
 <result pre="is burdened with the second largest number of TB and" exact="MDR-TB" post="cases with an estimated 886,000â€‰TB patients (including TB/HIV co-infection),"/>
 <result pre="one of four municipalities directly under the control of the" exact="Central" post="Government of China, which is located in southwest China"/>
 <result pre="in Chongqing faced many challenges, such as the prevalence of" exact="MDR-TB" post="and TB/HIV co-infection. Since the implementation of the 12th"/>
 <result pre="Chinaâ€™s TB control model has transformed from the â€œCenter for" exact="Disease" post="Control and Prevention (CDC) modelâ€� to the â€œintegrated modelâ€�"/>
 <result pre="control. Designated hospitals are responsible for TB diagnosis and treatment." exact="Primary" post="healthcare facilities are responsible for case management and patient"/>
 <result pre="to identify the population at higher risk of DR-TB and" exact="HIV-positive" post="TB to provide evidence that can serve as a"/>
 <result pre="hospital with Grade A level of prevention and treatment for" exact="infectious diseases" post="in Chongqing. In addition, CPHMC, as the Medical Quality"/>
 <result pre="as the Medical Quality Control Center of TB, HIV, and" exact="respiratory" post="infectious diseases, is the officially designated hospital for diagnosis"/>
 <result pre="the Medical Quality Control Center of TB, HIV, and respiratory" exact="infectious diseases," post="is the officially designated hospital for diagnosis and treatment"/>
 <result pre="all notified TB patients to the China Information System for" exact="Disease" post="Control and Prevention (CIS-DCP). A total of 1827 patients"/>
 <result pre="China Information System for Disease Control and Prevention (CIS-DCP). A" exact="total" post="of 1827 patients with pulmonary TB attended CPHMC to"/>
 <result pre="Control and Prevention (CIS-DCP). A total of 1827 patients with" exact="pulmonary" post="TB attended CPHMC to receive TB treatment from 1"/>
 <result pre="age, gender, occupation, living region, ethnicity, symptoms, and drug-related hepatotoxicity," exact="viral hepatitis," post="TB type, and HIV infection. Observational variables in this"/>
 <result pre="ethnicity, symptoms, and drug-related hepatotoxicity, viral hepatitis, TB type, and" exact="HIV infection." post="Observational variables in this study included demographic and clinical"/>
 <result pre="Hr-TB in our study. Mono-resistant TB (MR-TB) refers to Mycobacterium" exact="tuberculosis" post="strains with resistance to one first-line anti-TB drug [5]."/>
 <result pre="tuberculosis strains with resistance to one first-line anti-TB drug [5]." exact="MDR-TB" post="is defined as TB that is simultaneously resistant to"/>
 <result pre="requires treatment with second-line drugs [1]. XDR-TB is defined as" exact="MDR-TB" post="plus resistance to at least one drug in both"/>
 <result pre="which are the two most important classes of medicines in" exact="MDR-TB" post="treatment [21]. Poly-drug-resistance (PDR-TB) refers to resistance to more"/>
 <result pre="a second-line regimen [14]. INH-resistant TB (Hr-TB) refers to M." exact="tuberculosis" post="strains with resistance to INH and susceptibility to RFP"/>
 <result pre="refers to M. tuberculosis strains with resistance to INH and" exact="susceptibility to" post="RFP confirmed in vitro [21]. The results of this"/>
 <result pre="the differences in demographic and clinical characteristics among DR-TB and" exact="HIV-positive" post="TB patients. Based on the results of univariate analysis,"/>
 <result pre="clinical characteristics of patients are illustrated in TableÂ 1. A" exact="total" post="of 1827 patients were included in our study, and"/>
 <result pre="and 66.1% (nâ€‰=â€‰1207) were from the county/district of Chongqing. A" exact="total" post="of 565 (30.90%) patients were farmers, 510 (27.9%) were"/>
 <result pre="Characteristics Categories Number (N) Percent (%) Gender(Nâ€‰=â€‰1827) Male 1197 65.50" exact="Female" post="630 34.50 Ethnicity(Nâ€‰=â€‰1827) Han 1670 91.40 Others 157 8.60"/>
 <result pre="5.50 Manual worker 68 3.70 Others 151 8.30 Living region(Nâ€‰=â€‰1827)" exact="Central" post="urban 620 33.90 County/district 1207 66.10 Age(Nâ€‰=â€‰1827) â‰¤20 224"/>
 <result pre="77.10 Drug-related hepatotoxicity(NÂ =â€‰1827) Yes 749 41.00 No 1078 59.00" exact="Viral" post="hepatitis(Nâ€‰=â€‰1827) Yes 44 2.40 No 1783 97.60 AIDS/HIV(Nâ€‰=â€‰1827) Yes"/>
 <result pre="1783 97.60 AIDS/HIV(Nâ€‰=â€‰1827) Yes 110 6.00 No 1717 94.00 DR-TB(Nâ€‰=â€‰455)" exact="MDR-TB" post="396 87.03 MR-TB 18 4.00 XDR-TB 16 3.50 PDR-TB"/>
 <result pre="P (Ï‡2test) Gender Male 292 (64.2) 0.495 87 (7.3) 0.002*" exact="Female" post="163 (25.90) 23 (3.70) Ethnicity Han 399 (23.90) 0.002*"/>
 <result pre="(23.50) 3 (4.40) Others 33 (21.90) 6 (4.00) Living region" exact="Central" post="urban 128 (20.60) 0.001* 51 (8.20) 0.007* County/district 327"/>
 <result pre="(43.70) * 53 (7.10) 0.133 No 128 (11.90) 57 (5.30)" exact="Viral hepatitis" post="Yes 10 (22.70) 0.861 2 (4.50) 1.000 No 445"/>
 <result pre="* 53 (7.10) 0.133 No 128 (11.90) 57 (5.30) Viral" exact="hepatitis" post="Yes 10 (22.70) 0.861 2 (4.50) 1.000 No 445"/>
 <result pre="regression is shown in TableÂ 3. TB type and HIV" exact="infectious" post="status were the dependent variables (Y). Gender, ethnicity, occupation,"/>
 <result pre="lived in county/district were less likely to be HIV positive." exact="Female" post="patients were less likely to be HIV/AIDS positive than"/>
 <result pre="be HIV positive. Female patients were less likely to be" exact="HIV/AIDS" post="positive than male patients. However, compared with farmers, patients"/>
 <result pre="and patients aged 21â€&quot;60â€‰years had a higher risk of being" exact="HIV-positive" post="than those aged less than 21â€‰years and more than"/>
 <result pre="co-infection Variables Categories DR-TBOR(95%CI) TB/HIV co-infection OR(95%CI) Gender Male Reference" exact="Female" post="0.468 (0.286,0.765) Occupation Farmer Reference Reference Others 0.340 (0.128.0.905)"/>
 <result pre="Reference Reference Others 0.340 (0.128.0.905) Unemployed 2.013 (1.256,3.226) Living region" exact="Central" post="urban Reference County/district 0.644 (0.429,0.968) Age â‰¤20 Reference 21â€&quot;40"/>
 <result pre="farmers and unemployed individuals who lived in county/district had higher" exact="susceptibility to" post="TB in Chongqing. In 2015, the WHO proposed a"/>
 <result pre="of TB patients had MDR-TB. This study found that the" exact="MDR-TB" post="rate was slightly lower than 23.8%, which was the"/>
 <result pre="MDR-TB. This study found that the MDR-TB rate was slightly" exact="lower" post="than 23.8%, which was the value reported by another"/>
 <result pre="Chongqing is serious and cannot be ignored. Since the first" exact="HIV infection" post="was reported in Chongqing, the epidemic has developed particularly"/>
 <result pre="is serious and cannot be ignored. Since the first HIV" exact="infection" post="was reported in Chongqing, the epidemic has developed particularly"/>
 <result pre="DR-TB patients are co-infected with HIV, which has aggregated the" exact="disease" post="burden and increased poor outcomes [39â€&quot;41]. Therefore, it is"/>
 <result pre="other [39â€&quot;41, 47]. However, this study found no association between" exact="HIV-positive" post="and DR-TB patients among TB patients in Chongqing. This"/>
 <result pre="poorer economic conditions. Besides, patients who received retreatment had a" exact="lower" post="risk of being HIV positive, which may be due"/>
 <result pre="be due to the high mortality and default rate of" exact="HIV-positive" post="TB patients. A low retreatment rate was observed among"/>
 <result pre="HIV-positive TB patients. A low retreatment rate was observed among" exact="HIV-positive" post="TB patients. Our study has some limitations. First, cases"/>
 <result pre="led to bias in the measurement of the association between" exact="HIV-positive" post="TB and DR-TB. Conclusion Young men and socially disadvantaged"/>
 <result pre="Supplementary information LINK Additional file 1. Abbreviations CDC Center for" exact="Disease" post="Control and Prevention CIS-DCP China Information System for Disease"/>
 <result pre="for Disease Control and Prevention CIS-DCP China Information System for" exact="Disease" post="Control And Prevention CPHMC The Chongqing Public Health Medical"/>
 <result pre="Prevention CPHMC The Chongqing Public Health Medical Center DR-TB Drug-Resistant" exact="Tuberculosis" post="Hr-TB Isoniazid-Resistant Tuberculosis MDR-TB Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant Tuberculosis"/>
 <result pre="Chongqing Public Health Medical Center DR-TB Drug-Resistant Tuberculosis Hr-TB Isoniazid-Resistant" exact="Tuberculosis" post="MDR-TB Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant Tuberculosis PDR-TB Poly-Drug-Resistance Tuberculosis"/>
 <result pre="Public Health Medical Center DR-TB Drug-Resistant Tuberculosis Hr-TB Isoniazid-Resistant Tuberculosis" exact="MDR-TB" post="Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant Tuberculosis PDR-TB Poly-Drug-Resistance Tuberculosis RR/TB"/>
 <result pre="Medical Center DR-TB Drug-Resistant Tuberculosis Hr-TB Isoniazid-Resistant Tuberculosis MDR-TB Multidrug-Resistant" exact="Tuberculosis" post="MR-TB Mono-Resistant Tuberculosis PDR-TB Poly-Drug-Resistance Tuberculosis RR/TB Rifampicin-Resistant Tuberculosis"/>
 <result pre="Drug-Resistant Tuberculosis Hr-TB Isoniazid-Resistant Tuberculosis MDR-TB Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant" exact="Tuberculosis" post="PDR-TB Poly-Drug-Resistance Tuberculosis RR/TB Rifampicin-Resistant Tuberculosis STROBE Strengthening the"/>
 <result pre="Isoniazid-Resistant Tuberculosis MDR-TB Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant Tuberculosis PDR-TB Poly-Drug-Resistance" exact="Tuberculosis" post="RR/TB Rifampicin-Resistant Tuberculosis STROBE Strengthening the Reporting of Observational"/>
 <result pre="Multidrug-Resistant Tuberculosis MR-TB Mono-Resistant Tuberculosis PDR-TB Poly-Drug-Resistance Tuberculosis RR/TB Rifampicin-Resistant" exact="Tuberculosis" post="STROBE Strengthening the Reporting of Observational studies in Epidemiology"/>
 <result pre="STROBE Strengthening the Reporting of Observational studies in Epidemiology TB" exact="Tuberculosis" post="WHO World Health Organization Publisherâ€™s Note Springer Nature remains"/>
 <result pre="Technology Innovation Subject in Chongqing (cstc2015shmszx120070), the Technology Basic and" exact="Advanced" post="Research Projects in Chongqing (cstc2014jcyjA10069). The funders had no"/>
 <result pre="no competing interests. References References 1.collab: World Health Organization (WHO)Global" exact="tuberculosis" post="report2019 2.ShahMReedCComplications of tuberculosisCurr Opin Infect Dis20142740341025028786 3.collab: World"/>
 <result pre="programmatic management of drug-resistant tuberculosis2010 4.Beauvais S. Management of multi-DR" exact="tuberculosis" post="in children: A Field Guide. GHD online. https://www.ghdonline.org/drtb/discussion/practical-guidance-for-pediatric-mdr-tb-management/?ref=profile_detail. Accessed"/>
 <result pre="GHD online. https://www.ghdonline.org/drtb/discussion/practical-guidance-for-pediatric-mdr-tb-management/?ref=profile_detail. Accessed 2012. 5.BarnesPFBlochABDavidsonPTSniderDETuberculosis in patients with human" exact="immunodeficiency" post="virus infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of human immunodeficiency"/>
 <result pre="human immunodeficiency virus infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of human" exact="immunodeficiency" post="virus infection on the epidemiology, clinical features, management, and"/>
 <result pre="immunodeficiency virus infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of human immunodeficiency" exact="virus infection" post="on the epidemiology, clinical features, management, and control of"/>
 <result pre="virus infectionN Engl J Med1991324164416502030721 6.HopewellPCImpact of human immunodeficiency virus" exact="infection" post="on the epidemiology, clinical features, management, and control of"/>
 <result pre="and control of tuberculosisClin Infect Dis1992155405471520806 7.LucasSBDe CockKMHounnouAPeacockCDiomandeMHondeMet al.Contribution of" exact="tuberculosis" post="to slim disease in AfricaBMJ.1994308153115337912597 8.collab: The Fifth National"/>
 <result pre="tuberculosisClin Infect Dis1992155405471520806 7.LucasSBDe CockKMHounnouAPeacockCDiomandeMHondeMet al.Contribution of tuberculosis to slim" exact="disease" post="in AfricaBMJ.1994308153115337912597 8.collab: The Fifth National Tuberculosis Epidemiological Sampling"/>
 <result pre="tuberculosis to slim disease in AfricaBMJ.1994308153115337912597 8.collab: The Fifth National" exact="Tuberculosis" post="Epidemiological Sampling Survey Technical Steering GroupThe fifth National Tuberculosis"/>
 <result pre="National Tuberculosis Epidemiological Sampling Survey Technical Steering GroupThe fifth National" exact="Tuberculosis" post="Epidemiology Sampling Survey reportChin J Ant tuberculosis201234485508 9.ZhouZWTaoLHHuDYLiQMaJJYiJAnalysis the"/>
 <result pre="reportChin J Ant tuberculosis201234485508 9.ZhouZWTaoLHHuDYLiQMaJJYiJAnalysis the epidemiological and trends of" exact="pulmonary" post="tuberculosis from 1998 to 2009 in Chongqing and discussion"/>
 <result pre="J Ant tuberculosis201234485508 9.ZhouZWTaoLHHuDYLiQMaJJYiJAnalysis the epidemiological and trends of pulmonary" exact="tuberculosis" post="from 1998 to 2009 in Chongqing and discussion on"/>
 <result pre="Survey of TB epidemiology2011BeijingMilitary Medical Science Press17p 11.WuBYuYXieWLiuYZhangYHuDet al.Epidemiology of" exact="tuberculosis" post="in Chongqing, China: a secular trend from 1992 to"/>
 <result pre="trend from 1992 to 2015Sci Rep20177783228798367 12.collab: Chinese Center for" exact="Disease" post="Control and PreventionChina Tuberculosis Surveillance Report2010 13.LiuYLiuJJingKHChenIShenJAnalysis on monitoring"/>
 <result pre="2015Sci Rep20177783228798367 12.collab: Chinese Center for Disease Control and PreventionChina" exact="Tuberculosis" post="Surveillance Report2010 13.LiuYLiuJJingKHChenIShenJAnalysis on monitoring results of resistance of"/>
 <result pre="HIV)Pulmonology.20172411511929275968 15.ChenWYWeiXLi T, Chen H. analysis of global and Chinese" exact="tuberculosis" post="epidemics in 2015J Tuberc Lung Health20161323616 16.ZouGYWeiXLWalleyJDYinJSunQFactors influencing integration"/>
 <result pre="Family Planning Commission of the people's Republic of ChinaDiagnosis for" exact="pulmonary" post="tuberculosis2017 18.collab: Department of Disease Control and Department of"/>
 <result pre="people's Republic of ChinaDiagnosis for pulmonary tuberculosis2017 18.collab: Department of" exact="Disease" post="Control and Department of Medical Administration of Ministry of"/>
 <result pre="Administration of Ministry of Health of PRC, Chinese Center for" exact="Disease" post="Control and PreventionGuidelines for implementing the national tuberculosis control"/>
 <result pre="Center for Disease Control and PreventionGuidelines for implementing the national" exact="tuberculosis" post="control program in China2008BeijingPeking Union Medical College Press 19.Chongqing"/>
 <result pre="center. Available: http://www.cqgwzx.com/column/about/zhongxinjianjie/. 20.HuangFChengSDuXChenWScanoFFalzonDet al.Electronic recording and reporting system for" exact="tuberculosis" post="in China: experience and opportunitiesJ Am Med Inform Assoc20142193894124326537"/>
 <result pre="Am Med Inform Assoc20142193894124326537 21.collab: World Health Organization (WHO)Extensively DR" exact="tuberculosis" post="(XDR.TB): recommendations for prevention and controlWkly Epidemiol Rec20068143043217096498 22.collab:"/>
 <result pre="multidrug and rifampicin-resistant tuberculosis2018 23.WangYZhangFMLuoKWMengJRegional and occupational distribution of 335" exact="MDR-TB" post="cases in Guizhou ProvinceJ Guiyang Med College201237302303 24.PuJChenWJiangWXXingWLiangSXLiYet al.Is"/>
 <result pre="MDR-TB cases in Guizhou ProvinceJ Guiyang Med College201237302303 24.PuJChenWJiangWXXingWLiangSXLiYet al.Is" exact="tuberculosis" post="patients management improved in the integrated TB control model"/>
 <result pre="Res Pract Higher Inst20052710 30.PangYWuCGLiuYZhangTDuanWXYuYet al.Analysis of the disposal of" exact="tuberculosis" post="clusters in schools in Chongqing in 2017Chin J Tropical"/>
 <result pre="2017Chin J Tropical Med201919799 31.PangYLiuYWangQYAn overview of the prevalence of" exact="tuberculosis" post="epidemics in schools in Chongqing in 2016Pract Prev Med201811013"/>
 <result pre="China: is the information reaching the target?BMJ Open20133e00345424056486 33.WangQYHuDYLiuYShenJChongqing City" exact="tuberculosis" post="drug resistance analysisChongqing Med20142229132915 34.ZhangWHuDYLiuYYuYSuQZhangTPrevalence of multidrug-resistance in 638"/>
 <result pre="tuberculosis drug resistance analysisChongqing Med20142229132915 34.ZhangWHuDYLiuYYuYSuQZhangTPrevalence of multidrug-resistance in 638" exact="tuberculosis" post="patients in ChongqingChin J Tropical Med201717231235 35.YuHYZhangWLuRRWuGHSuKZhangYet al.The epidemiological"/>
 <result pre="Tropical Med201717231235 35.YuHYZhangWLuRRWuGHSuKZhangYet al.The epidemiological characteristics and long-term trend of" exact="HIV infection" post="and AIDS in Chongqing from 1995 to 2015J Third"/>
 <result pre="Med201717231235 35.YuHYZhangWLuRRWuGHSuKZhangYet al.The epidemiological characteristics and long-term trend of HIV" exact="infection" post="and AIDS in Chongqing from 1995 to 2015J Third"/>
 <result pre="2015J Third Mil Med Univ20172020512058 36.collab: World Health Organization (WHO)Global" exact="tuberculosis" post="control report2013 37.TsiourisSJGandhiNREl-SadrWMFriedlandGTuberculosis and HIV-needed: a new paradigm for"/>
 <result pre="the importance of homelessness, problem drug use and prisonThorax.20076266767117289861 40.DubrovinaIMiskinisKLyepshinaSYannYZignolMDR" exact="tuberculosis" post="and HIV in Ukraine: a threatening convergence of two"/>
 <result pre="and challenges aheadBMC Public Health20111111021324205 44.PamOINoelOSusanOFlorenceMJoshuaNPere-JoanCPrevalence of drug resistance Mycobacterium" exact="tuberculosis" post="among patients seen in coast provincial general hospital, mombasa,"/>
 <result pre="46.HutchisonCKhanMSYoongJLinXCokerRJFinancial barriers and coping strategies: a qualitative study of accessing" exact="multidrug-resistant tuberculosis" post="and tuberculosis care in Yunnan, ChinaBMC Public Health20171722128222724 47.BastardMSanchez-PadillaEdu"/>
 <result pre="barriers and coping strategies: a qualitative study of accessing multidrug-resistant" exact="tuberculosis" post="and tuberculosis care in Yunnan, ChinaBMC Public Health20171722128222724 47.BastardMSanchez-PadillaEdu"/>
 <result pre="coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and" exact="tuberculosis" post="care in Yunnan, ChinaBMC Public Health20171722128222724 47.BastardMSanchez-PadillaEdu CrosPKhamraevAKParpievaNTillyashaykovMet al.Outcomes"/>
 <result pre="One201813e019349129518098 48.MaoSYXuSXComparative analysis of drug resistance of AIDS combined with" exact="tuberculosis" post="and simple tuberculosisMed Front2016238 49.XiaHA molecular epidemiological study on"/>
 <result pre="tuberculosis and simple tuberculosisMed Front2016238 49.XiaHA molecular epidemiological study on" exact="HIV/AIDS" post="patients of Han nationality from Chongqing2009ChinaThird Military Medical University"/>
</results>
